Patrick Roth

192 papers receiving 7.1k citations

Patrick Roth's Hit Papers

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma 2020 · 946 citations
9460+2+4Years since publication250500750

Peers

Patrick Roth
Comparison fields: 5 of 137
  • Genetics 3.2k
  • Neurology 1.3k
  • Cancer Research 1.1k
  • Immunology 1.5k
  • Oncology 1.9k
Replace Ryo Nishikawa with:
Ryo Nishikawa Japan
Katrin Lamszus Germany
Annick Desjardins United States
Burt Nabors United States
Mathilde C.M. Kouwenhoven Netherlands
Kristin Waite United States
Tobey J. MacDonald United States
Donald M. O’Rourke United States
Ken Aldape United States
Elisabeth J. Rushing United States
Patrick Roth relative to Ryo Nishikawa Japan Ryo Nishikawa's profile →
Citations per field
00.5×
Ryo Nishikawa · 1×
Citations per year

Countries citing papers authored by Patrick Roth

Since Specialization
Citations

This map shows the geographic impact of Patrick Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Roth more than expected).

Fields of papers citing papers by Patrick Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Roth. The network helps show where Patrick Roth may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Roth Line = papers co-authored together Patrick Roth links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
Hit paper breakdown →
2020946
2
Molecular targeted therapy of glioblastoma
Hit paper breakdown →
2019466
3 1999281
4 2017231
5 2010224
6 2012172
7 2011172
8 2017161
9 2016147
10 2010139
11 2017121
12 2012118
13 2009108
14 202094
15 201391
16 201391
17 201790
18 201681
19 200781
20 200880

About Patrick Roth

Patrick Roth is a scholar working on Genetics, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Neurology, having authored 202 papers that have together received 7.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (106 papers), Brain Metastases and Treatment (35 papers), CNS Lymphoma Diagnosis and Treatment (22 papers), Immunotherapy and Immune Responses (16 papers), Lymphoma Diagnosis and Treatment (15 papers), Immune cells in cancer (13 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Genetics (3.2k citations), Neurology (1.3k citations), Cancer Research (1.1k citations), Immunology (1.5k citations) and Oncology (1.9k citations). Patrick Roth has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Michael Weller, David A. Reardon, Guido Reifenberger, Wolfgang Wick, Manuela Silginer, Caroline Happold, Matthias Preusser, Tobias Weiß, Émilie Le Rhun and Martin J. van den Bent. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Clinical Cancer Research and Current Opinion in Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact